Last reviewed · How we verify

NCT06634147: PREDISC

Prevention of Functional and Cognitive Impairment Through a Multicomponent Exercise Program in Hospitalized Older Adults

Recruiting now NA Last updated 18 July 2025
What this trial tests

NA trial testing Exercise in Clinical Deterioration in 296 participants. Currently enrolling.

Timeline
1 February 2025
Primary endpoint
1 November 2026
1 December 2026

Quick facts

Lead sponsorFundacion Miguel Servet
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment296
Start date1 February 2025
Primary completion1 November 2026
Estimated completion1 December 2026
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundacion Miguel Servet

Who can join

75 and older, any sex, with Clinical Deterioration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to determine whether a multicomponent exercise program improves functional capacity and cognitive status in hospitalized elderly patients aged 75 and older. Additionally, the study aims to assess the impact of this program on medication use, quality of life, and overall health outcomes. Key questions include whether the program enhances functional and cognitive capacities and which subgroups benefit most, such as frail patients or those with cognitive impairment. Participants will engage in a structured exercise program that includes strength training, balance exercises, and walking, all designed to improve mobility and reduce fall risk. They will attend supervised sessions several times a week, allowing for individualized attention and adjustments based on their abilities and health status. Throughout the study, changes in functional capacity will be monitored using standardized assessments that measure mobility, strength, and overall physical functioning. Cognitive assessments will evaluate any changes in cognitive status during the intervention and follow-up periods post-discharge. Participants will provide information on medication usage to analyze whether the exercise program can reduce the need for medications or help manage common polypharmacy issues. Surveys and interviews will assess participants' quality of life, including physical, emotional, and social well-being, before and after the intervention. Follow-up assessments will track progress and outcomes, ensuring long-term benefits of the exercise program are documented. The study will include a diverse sample from multiple centers, focusing on individuals aged over 75 who are hospitalized in Geriatrics and Internal Medicine services across participating centers (HUN, CHU-T, ULSBM, and HNSM). Exclusion criteria will ensure safety, excluding those with terminal illnesses or significant contraindications for exercise. This clinical trial aims to recruit 296 patients, providing valuable insights into the benefits of physical activity for elderly patients during hospitalization and informing future care practices.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prevention of functional and cognitive impairment through a multicomponent exercise program during and after hospitalization of older adults (PREDISC): Study protocol for a multicenter randomized clinical trial.
    Martínez-Velilla N, Santos Silva R, Rodriguez PA, Xandri JM, et al · · 2025 · PMID 40997056 · DOI 10.1371/journal.pone.0332391

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Clinical Deterioration

Currently open trials in the same condition.

Other Fundacion Miguel Servet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06634147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing